François Ducray Selected Research

François Ducray Research Topics

Disease

46	Neoplasms (Cancer) 04/2024 - 09/2006
34	Glioma (Gliomas) 03/2024 - 09/2007
22	Glioblastoma (Glioblastoma Multiforme) 04/2024 - 09/2006
11	Encephalitis (Encephalitis, Rasmussen) 05/2023 - 02/2014
8	Oligodendroglioma 06/2023 - 05/2008
6	Astrocytoma (Pilocytic Astrocytoma) 12/2023 - 11/2009
5	Disease Progression 01/2024 - 08/2011
5	Brain Neoplasms (Brain Tumor) 08/2023 - 07/2011
5	Autoimmune Diseases of the Nervous System 10/2018 - 05/2014
4	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 07/2021 - 01/2016
4	Seizures (Absence Seizure) 02/2016 - 07/2011
3	Necrosis 12/2019 - 02/2011
2	Pituitary Neoplasms (Pituitary Adenoma) 01/2024 - 03/2012
2	Carcinoma (Carcinomatosis) 01/2024 - 03/2012
2	Cerebellar Ataxia (Dysmetria) 07/2021 - 07/2017
2	Temporal Lobe Epilepsy 07/2021 - 07/2020
2	Nervous System Paraneoplastic Syndromes 11/2019 - 09/2015
2	Ganglioglioma 01/2019 - 11/2017
2	Lymphoma (Lymphomas) 01/2017 - 11/2015
2	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 10/2016 - 12/2015
2	Thymoma (Thymic Carcinoma) 01/2016 - 03/2007
2	Epilepsy (Aura) 12/2013 - 06/2013
1	Craniopharyngioma (Craniopharyngiomas) 12/2023
1	Neuroblastoma 11/2023
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 01/2023
1	Genetic Predisposition to Disease (Genetic Predisposition) 07/2021
1	Ewing Sarcoma (Sarcoma, Ewing) 07/2021
1	Stiff-Person Syndrome (Stiff Man Syndrome) 07/2021
1	Nervous System Diseases (Neurological Disorders) 07/2021
1	Angiomatoid Fibrous Histiocytoma 07/2021
1	Meningioma (Meningiomas) 05/2021
1	Myelitis 01/2021
1	Paralysis (Palsy) 01/2021
1	Cranial Nerve Diseases (Cranial Nerve Disorders) 01/2021

Drug/Important Bio-Agent (IBA)

16	Temozolomide (Temodar)FDA LinkGeneric 01/2024 - 09/2007
13	AntibodiesIBA 07/2021 - 03/2007
11	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 12/2023 - 09/2009
9	Lomustine (CCNU)FDA Link 01/2024 - 07/2011
9	Proteins (Proteins, Gene)FDA Link 12/2023 - 11/2007
9	Biomarkers (Surrogate Marker)IBA 05/2022 - 09/2007
8	Procarbazine (Matulane)FDA Link 01/2023 - 07/2011
8	Vincristine (Oncovin)FDA LinkGeneric 01/2023 - 07/2011
7	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 10/2018 - 02/2014
6	Bevacizumab (Avastin)FDA Link 01/2024 - 09/2008
4	Immune Checkpoint InhibitorsIBA 03/2024 - 11/2019
4	AutoantibodiesIBA 05/2023 - 05/2014
4	Histones (Histone)IBA 11/2018 - 03/2016
4	alpha-internexinIBA 11/2011 - 05/2008
4	MethyltransferasesIBA 07/2011 - 09/2009
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2023 - 09/2008
3	Mitogen-Activated Protein KinasesIBA 01/2023 - 11/2009
3	SteroidsIBA 01/2020 - 02/2011
3	Irinotecan (Camptosar)FDA LinkGeneric 05/2018 - 09/2008
2	14- methyl- 20- oxa- 5,7,14,26- tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8(27),9,11,16,21,23- decaeneIBA 04/2024 - 12/2023
2	SteamIBA 04/2024 - 12/2023
2	NivolumabIBA 03/2024 - 11/2019
2	Tyrosine Kinase InhibitorsIBA 01/2024 - 09/2008
2	Alkylating AgentsIBA 12/2023 - 11/2007
2	RNA (Ribonucleic Acid)IBA 06/2023 - 11/2018
2	Everolimus FDA Link 11/2021 - 03/2012
2	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 07/2021 - 07/2020
2	Carmustine (FIVB)FDA Link 01/2021 - 09/2007
2	IpilimumabIBA 01/2020 - 11/2019
2	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2019 - 11/2017
2	ParaffinIBA 01/2019 - 01/2016
2	Formaldehyde (Formol)FDA Link 01/2019 - 01/2016
2	N-Methylaspartate (NMDA)IBA 02/2016 - 08/2015
2	Anticonvulsants (Antiepileptic Drugs)IBA 12/2013 - 06/2013
2	O(6)-Methylguanine-DNA MethyltransferaseIBA 08/2011 - 05/2011
2	DNA (Deoxyribonucleic Acid)IBA 07/2011 - 05/2010
2	Codon (Codons)IBA 09/2009 - 09/2007
1	Carboplatin (JM8)FDA LinkGeneric 02/2024
1	MTOR InhibitorsIBA 01/2024
1	Peptides (Polypeptides)IBA 01/2024
1	Radioisotopes (Radionuclides)IBA 01/2024
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 12/2023
1	BMH-21IBA 12/2023
1	CX 5461IBA 12/2023
1	Ribosomal RNAIBA 12/2023
1	4-O-carboxymethylascochlorinIBA 12/2023
1	SuspensionsIBA 11/2023
1	vorasidenibIBA 08/2023
1	EnzymesIBA 08/2023
1	Somatotropin Receptors (Growth Hormone Receptor)IBA 01/2022
1	Sorafenib (BAY 43-9006)FDA Link 11/2021
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 11/2021
1	ruxolitinibIBA 11/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2021
1	Transcription Factors (Transcription Factor)IBA 07/2021
1	Cyclic AMP (AMP, Cyclic)IBA 07/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021
1	GlucocorticoidsIBA 01/2021

Therapy/Procedure

23	Drug Therapy (Chemotherapy) 03/2024 - 09/2007
15	Radiotherapy 03/2024 - 12/2008
10	Therapeutics 01/2024 - 09/2008
5	Aftercare (After-Treatment) 06/2023 - 01/2015
3	Immunotherapy 01/2024 - 06/2013
2	Precision Medicine 01/2022 - 11/2021
2	Adjuvant Chemotherapy 01/2021 - 09/2007
2	Chemoradiotherapy 05/2018 - 05/2011